Robot-Assisted Dental Surgery: Mirae Asset Supports Neocis in Financing Round

2 minute read | January.17.2024

Venture capital funds affiliated with Mirae Asset Financial Group have participated in a financing round for Neocis, the global leader in robot-assisted dental implant surgery.

Orrick advised Mirae.

Mirae Asset Capital and Mirae Asset Venture Investment, venture capital funds affiliated with Mirae Asset Financial Group that invest in growth-stage healthcare and technology businesses, invested in Neocis. NVentures, NVIDIA’s venture capital arm, also participated in the round, which raised $20 million.


Founded in 1997, Mirae Asset is one of the largest independent financial groups in Asia, providing comprehensive services to clients worldwide. The company manages assets and offers services that include wealth management, investment banking and life insurance.

Mirae Asset Capital invests in businesses worldwide to promote industries creating new growth, with a focus on companies that power growth at the center of the Fourth Industrial Revolution. Mirae Asset Venture Investment empowers “exceptional entrepreneurs to create category defining high-growth companies.”

Neocis is transforming dental surgery with robotics. The company collaborates closely with leading clinicians across all dental specialties to develop innovative technologies that help advance patient care and improve quality of life. Neocis manufactures and markets Yomi, dentistry’s first and only robotic surgical system cleared by the U.S. Food and Drug Administration.


The investment “is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” Alon Mozes, Neocis’ co-founder and CEO, said in a statement.

“This funding positions us for continued success in the market and will help us drive meaningful innovation in implant dentistry,” he said.


Orrick’s Tony Chan and Elizabeth Lefever advised Mirae.


Neocis news release

Read More Orrick Client Results